Skip to main content
Caplight Logo









NZeno

NZeno

Private
AucklandHealthcare & Life Scienceshttps://nzeno.nz/

Last Round

Early Funding

Oct 1, 2023

Total Funding Raised

$2.99M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

NZeno is a biotechnology company that develops gene-edited pig-derived products for human xenotransplantation to address the global shortage of organs for kidney transplants.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

xenotransplantationgene-edited organsxenotransplantpig-to-human transplantDPFdesignated pathogen freeorgan shortagebiotechmedical-grade pig tissueCRISPRgene editingend-stage renal diseasepig cloningtransplant research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NZeno Comparables

Compare NZeno with similar companies based on industry and business-model similarity.

NZeno comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Makana Therapeutics
84%
PorMedTec Co., Ltd.
84%
ChoironeX
84%

NZeno Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingOct 1, 2023
SeedJul 1, 2017

Key People

Founding team and executive leadership

Olga Garkavenko

Director Founder, Chief Scientific Officer, Chief Technical Officer

Founding Team

NZeno Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 308% MoM, reaching 3.2K.

  • Jun 1, 2025

    Monthly visitors grew 285% MoM.

NZeno Filings

Explore SEC and related filing metadata, where available.

NZeno filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about NZeno's valuation, stock price, and market status.

Is NZeno a public or private company?

NZeno is a private company.

What is the current stock price of NZeno?

NZeno is a private company with no public stock price. No recent secondary market data is available.

How much is NZeno worth (valuation)?

Valuation information for NZeno is not publicly available.

Can I buy NZeno stock?

NZeno shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was NZeno's last funding round?

NZeno's most recent funding round was Early Funding on October 1, 2023.

Who are the main investors in NZeno?

Key investors in NZeno include Outset Ventures, New Zealand Growth Capital Partners, Cure Kids Ventures, Pacific Channel.

Will NZeno IPO soon?

No public IPO plans have been announced for NZeno.

How can I track NZeno secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NZeno's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAuckland
Employee Range2
Year Founded2016
Last FundingOct 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?